Trade JnJ JNJ

Sell
 Buy

JnJ live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close change Change (%) Open High Low

JnJ news

Tommy Yap 2025 Apr 12, 16:00

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Forex Indices
ECB set to cut rates for the third time this year
Neil Wilson 2024 Oct 10, 16:00

Week ahead: ECB set to cut as Wall Street earnings season gathers pace

Forex Indices
US earnings season kicks off, ECB expected to hold rates steady
Neil Wilson 2024 Jul 11, 21:00

Week ahead: US earnings season kicks off, ECB hold expected

Forex Indices
Oil steady, gold bearish trend
Neil Wilson 2024 Jan 22, 08:15

Europe Tries to Ride on US Coat-tails

Stocks Forex Commodities Indices
The Bank of Japan
Neil Wilson 2024 Jan 18, 08:07

Week ahead: ECB, BoJ rate decisions + Tesla earnings on tap

Forex Indices

Latest news

Show more
Tommy Yap 2025 May 22, 16:00

Morning Note: Japan's Core Inflation Spikes; UK Retail Surges; Canada Sales Slow

Morning Note
Frances Wang 2025 May 21, 16:00

What is the TQQQ ETF: What are the risks associated with TQQQ ETF?

ETFs
Tommy Yap 2025 May 21, 16:00

Morning Note: Nvidia Slams China Chip Ban; Bitcoin Climbs on Trade Peace;

Morning Note Tech Cryptocurrencies
Tommy Yap 2025 May 21, 16:00

Morning Note: UK Inflation Surprises Higher; Mideast Tensions Fuel Oil, Gold

Morning Note Commodities
Frances Wang 2025 May 20, 16:00

Palantir Stock Price Analysis: What is the prediction for PLTR?

Stocks
Frances Wang 2025 May 19, 16:00

Stock index news today: ASX 200 goes higher on RBA Rate Cut

Indices
Tommy Yap 2025 May 19, 16:00

Morning Note: RBA Eases Policy; Canada's Inflation Outlook; China Lowers Rates

Morning Note AUD CAD China
Tommy Yap 2025 May 19, 16:00

Morning Note: ECB Easing May Pause; Japan's Economic Slump; US Credit Caution

Morning Note

Info

Spread

1.00

Spread (%)

0.6561 %

Leverage

1:2

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Friday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

367190343680

Shares Outstanding

2406070016

Earnings Date (Next)

2001-06-13

instr__dividend_date

2025-06-10

instr__ex_dividend_date

2025-05-27

instr__forward_annual_dividend_rate

5.2

instr__forward_annual_dividend_yield

0.0339

EPS

8.99

Learn more about this instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Markets.com Bonus Trading

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Markets.com Bonus Trading
Trustpilot